Citations (99)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Claudio Napoli, Paola Bontempo, Vittorio Palmieri, Enrico Coscioni, Ciro Maiello, Francesco Donatelli & Giuditta Benincasa. (2021) Epigenetic Therapies for Heart Failure: Current Insights and Future Potential. Vascular Health and Risk Management 17, pages 247-254.
Read now
Read now
Yixiang Huang, Wei Jian, Junyong Zhao & Gang Wang. (2018) Overexpression of HDAC9 is associated with poor prognosis and tumor progression of breast cancer in Chinese females. OncoTargets and Therapy 11, pages 2177-2184.
Read now
Read now
Haloom Rafehi, Antony Kaspi, Mark Ziemann, Jun Okabe, Tom C. Karagiannis & Assam El-Osta. (2017) Systems approach to the pharmacological actions of HDAC inhibitors reveals EP300 activities and convergent mechanisms of regulation in diabetes. Epigenetics 12:11, pages 991-1003.
Read now
Read now
Luisa Politano & Giovanni Nigro. (2016) Managing dystrophinopathic cardiomyopathy. Expert Opinion on Orphan Drugs 4:11, pages 1159-1178.
Read now
Read now
Haloom Rafehi, Abdul Waheed Khan & Assam El-Osta. (2016) Improving understanding of chromatin regulatory proteins and potential implications for drug discovery. Expert Review of Proteomics 13:4, pages 435-445.
Read now
Read now
Articles from other publishers (94)
Manish Kumar Gupta. 2024. Epigenetics in Human Disease. Epigenetics in Human Disease
761
778
.
Floriana Maria Farina, Ignacio Fernando Hall, Christina Pagiatakis, Montserrat Climent & Leonardo Elia. 2024. Epigenetics in Human Disease. Epigenetics in Human Disease
717
759
.
Ashita Jain, Diego Casanova, Alejandra Valdivia Padilla, Angelica Paniagua Bojorges, Sivareddy Kotla, Kyung Ae Ko, Venkata S. K. Samanthapudi, Khanh Chau, Minh T. H. Nguyen, Jake Wen, Selina L. Hernandez Gonzalez, Shaefali P. Rodgers, Elizabeth A. Olmsted-Davis, Dale J. Hamilton, Cielito Reyes-Gibby, Sai-Ching J. Yeung, John P. Cooke, Joerg Herrmann, Eduardo N. Chini, Xiaolei Xu, Syed Wamique Yusuf, Momoko Yoshimoto, Philip L. Lorenzi, Brain Hobbs, Sunil Krishnan, Efstratios Koutroumpakis, Nicolas L. Palaskas, Guangyu Wang, Anita Deswal, Steven H. Lin, Jun-ichi Abe & Nhat-Tu Le. (2023) Premature senescence and cardiovascular disease following cancer treatments: mechanistic insights. Frontiers in Cardiovascular Medicine 10.
Crossref
Crossref
Chenxi Zhu, Zhehao Piao & Li Jin. (2023) HDAC5 inhibition attenuates ventricular remodeling and cardiac dysfunction. Orphanet Journal of Rare Diseases 18:1.
Crossref
Crossref
Zhen Guo, Yue-huai Hu, Guo-shuai Feng, Carla Valenzuela Ripoll, Zhen-zhen Li, Si-dong Cai, Qian-qian Wang, Wen-wei Luo, Qian Li, Li-ying Liang, Zhong-kai Wu, Ji-guo Zhang, Ali Javaheri, Lei Wang, Jing Lu & Pei-qing Liu. (2023) JMJD6 protects against isoproterenol-induced cardiac hypertrophy via inhibition of NF-κB activation by demethylating R149 of the p65 subunit. Acta Pharmacologica Sinica 44:9, pages 1777-1789.
Crossref
Crossref
Gang Jin, Kaiyue Wang, Yaohui Zhao, Shuo Yuan, Zhangxu He & Jingyu Zhang. (2023) Targeting histone deacetylases for heart diseases. Bioorganic Chemistry 138, pages 106601.
Crossref
Crossref
David Renaud, Sabine Scholl-Bürgi, Daniela Karall & Miriam Michel. (2023) Comparative Metabolomics in Single Ventricle Patients after Fontan Palliation: A Strong Case for a Targeted Metabolic Therapy. Metabolites 13:8, pages 932.
Crossref
Crossref
Qian Zhong, Xina Xiao, Yijie Qiu, Zhiqiang Xu, Chunyu Chen, Baochen Chong, Xinjun Zhao, Shan Hai, Shuangqing Li, Zhenmei An & Lunzhi Dai. (2023) Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications. MedComm 4:3.
Crossref
Crossref
K. A. Aitbaev, I. T. Murkamilov, V. V. Fomin, Zh. A. Murkamilova, I. O. Kudaibergenova & F. A. Yusupov. (2023) Effectiveness of apabetalone and some other indirect epigenetic-oriented drugs in the treatment of heart failure. Cardiovascular Therapy and Prevention 22:4, pages 3457.
Crossref
Crossref
Gaia Papini, Giulia Furini, Marco Matteucci, Vanessa Biemmi, Valentina Casieri, Nicole Di Lascio, Giuseppina Milano, Lucia Rosa Chincoli, Francesco Faita, Lucio Barile & Vincenzo Lionetti. (2023) Cardiomyocyte-targeting exosomes from sulforaphane-treated fibroblasts affords cardioprotection in infarcted rats. Journal of Translational Medicine 21:1.
Crossref
Crossref
Vasco Sequeira, Mark T. Waddingham, Hirotsugu Tsuchimochi, Christoph Maack & James T. Pearson. (2023) Mechano-energetic uncoupling in hypertrophic cardiomyopathy: Pathophysiological mechanisms and therapeutic opportunities. Journal of Molecular and Cellular Cardiology Plus, pages 100036.
Crossref
Crossref
Yijia Li, Hajime Kubo, Daohai Yu, Yijun Yang, Jaslyn P. Johnson, Deborah M. Eaton, Remus M. Berretta, Michael Foster, Timothy A. McKinsey, Jun Yu, John W. Elrod, Xiongwen Chen & Steven R. Houser. (2023) Combining three independent pathological stressors induces a heart failure with preserved ejection fraction phenotype. American Journal of Physiology-Heart and Circulatory Physiology 324:4, pages H443-H460.
Crossref
Crossref
Jieyu Ren, Qun Zeng, Hongmei Wu, Xuewen Liu, Maria C. Guida, Wen Huang, Yiyuan Zhai, Junjie Li, Karen Ocorr, Rolf Bodmer & Min Tang. (2023) Deacetylase‐dependent and ‐independent role of HDAC3 in cardiomyopathy. Journal of Cellular Physiology 238:3, pages 647-658.
Crossref
Crossref
Santosh K Sanganalmath, Shubham Dubey, Sudhakar Veeranki, Keerthy Narisetty & Prasanna Krishnamurthy. (2023) The interplay of inflammation, exosomes and Ca2+ dynamics in diabetic cardiomyopathy. Cardiovascular Diabetology 22:1.
Crossref
Crossref
Timothy A McKinsey, Roger Foo, Chukwuemeka George Anene-Nzelu, Joshua G Travers, Ronald J Vagnozzi, Natalie Weber & Thomas Thum. (2022) Emerging epigenetic therapies of cardiac fibrosis and remodelling in heart failure: from basic mechanisms to early clinical development. Cardiovascular Research 118:18, pages 3482-3498.
Crossref
Crossref
Kaihao Wang, Youhong Zhang, Min Zhou, Yipeng Du, Peixin Li, Chang Guan & Zheng Huang. (2023) HDAC Inhibitors Alleviate Uric Acid–Induced Vascular Endothelial Cell Injury by Way of the HDAC6/FGF21/PI3K/AKT Pathway. Journal of Cardiovascular Pharmacology 81:2, pages 150-164.
Crossref
Crossref
Chiara Papulino, Ugo Chianese, Lucia Scisciola, Ahmad Ali, Michelangela Barbieri, Giuseppe Paolisso, Lucia Altucci & Rosaria Benedetti. 2023. Cancer Epigenetics. Cancer Epigenetics
295
329
.
Midori Yukino-Iwashita, Yuji Nagatomo, Akane Kawai, Akira Taruoka, Yusuke Yumita, Kazuki Kagami, Risako Yasuda, Takumi Toya, Yukinori Ikegami, Nobuyuki Masaki, Yasuo Ido & Takeshi Adachi. (2022) Short-Chain Fatty Acids in Gut–Heart Axis: Their Role in the Pathology of Heart Failure. Journal of Personalized Medicine 12:11, pages 1805.
Crossref
Crossref
Takaharu Kimura, Cristina Panaroni, Erinn B. Rankin, Louise E. Purton & Joy Y. Wu. (2022) Loss of Parathyroid Hormone Receptor Signaling in Osteoprogenitors Is Associated With Accumulation of Multiple Hematopoietic Lineages in the Bone Marrow. Journal of Bone and Mineral Research 37:7, pages 1321-1334.
Crossref
Crossref
Samuele Ambrosini, Era Gorica, Shafeeq A. Mohammed, Sarah Costantino, Frank Ruschitzka & Francesco Paneni. (2022) Epigenetic remodeling in heart failure with preserved ejection fraction. Current Opinion in Cardiology 37:3, pages 219-226.
Crossref
Crossref
Jingjing Wan, Zhen Zhang, Saisai Tian, Si Huang, Huizi Jin, Xia Liu & Weidong Zhang. (2022) Single cell study of cellular diversity and mutual communication in chronic heart failure and drug repositioning. Genomics 114:3, pages 110322.
Crossref
Crossref
Joshua G. Travers, Charles A. Tharp, Marcello Rubino & Timothy A. McKinsey. (2022) Therapeutic targets for cardiac fibrosis: from old school to next-gen. Journal of Clinical Investigation 132:5.
Crossref
Crossref
Preethika Ekanayake & Sunder Mudaliar. (2021) A novel hypothesis linking low‐grade ketonaemia to cardio‐renal benefits with sodium‐glucose cotransporter‐2 inhibitors. Diabetes, Obesity and Metabolism 24:1, pages 3-11.
Crossref
Crossref
Chukwuemeka G. Anene-Nzelu, Mick C. J. Lee, Wilson L. W. Tan, Albert Dashi & Roger S. Y. Foo. (2021) Genomic enhancers in cardiac development and disease. Nature Reviews Cardiology 19:1, pages 7-25.
Crossref
Crossref
Jindong Li, Chengyan Jin, Lihua Sun, Bin Wang, Peiyan Hua & Yan Zhang. (2021) HDAC2 enhances esophageal squamous cell carcinoma development through down-regulating microRNA-503-5p and promoting CXCL10. Clinical Epigenetics 13:1.
Crossref
Crossref
Sebastian Lunke, Scott Maxwell, Ishant Khurana, Harikrishnan K.N., Jun Okabe, Keith Al-Hasani & Assam El-Osta. (2021) Epigenetic evidence of an Ac/Dc axis by VPA and SAHA. Clinical Epigenetics 13:1.
Crossref
Crossref
Emily Catherine Cheung, Matthew Wyatt Kay & Kathryn Jaques Schunke. (2021) Epigenetic Alterations in Pediatric Sleep Apnea. International Journal of Molecular Sciences 22:17, pages 9523.
Crossref
Crossref
Judith Bernal-Ramirez, Magda C. Díaz-Vesga, Matias Talamilla, Andrea Méndez, Clara Quiroga, Javier A. Garza-Cervantes, Anay Lázaro-Alfaro, Carlos Jerjes-Sanchez, Mauricio Henríquez, Gerardo García-Rivas & Zully Pedrozo. (2021) Exploring Functional Differences between the Right and Left Ventricles to Better Understand Right Ventricular Dysfunction. Oxidative Medicine and Cellular Longevity 2021, pages 1-21.
Crossref
Crossref
Ashley Francois, Alessandro Canella, Lynn M. Marcho & Matthew S. Stratton. (2021) Protein acetylation in cardiac aging. Journal of Molecular and Cellular Cardiology 157, pages 90-97.
Crossref
Crossref
Xiaowen Shi, Bin Zhang, Zhenliang Chu, Bingjiang Han, Xueping Zhang, Ping Huang & Jibo Han. (2021) Wogonin Inhibits Cardiac Hypertrophy by Activating Nrf-2-Mediated Antioxidant Responses. Cardiovascular Therapeutics 2021, pages 1-13.
Crossref
Crossref
Yohei Sawa, Naoko Matsushita, Sachiko Sato, Nanae Ishida, Maki Saito, Atsushi Sanbe, Yoshihiro Morino, Eiichi Taira, Mami Obara & Masamichi Hirose. (2021) Chronic HDAC6 Activation Induces Atrial Fibrillation Through Atrial Electrical and Structural Remodeling in Transgenic Mice. International Heart Journal 62:3, pages 616-626.
Crossref
Crossref
Douglas J. Chapski & Thomas M. Vondriska. (2021) Taking Data Science to Heart: Next Scale of Gene Regulation. Current Cardiology Reports 23:5.
Crossref
Crossref
Yanming Li, Xiaofei Weng, Pingping Wang, Zezhao He, Siya Cheng, Dongxing Wang, Xianhui Li, Guanchang Cheng & Tao Li. (2021) 4-phenylbutyrate exerts stage-specific effects on cardiac differentiation via HDAC inhibition. PLOS ONE 16:4, pages e0250267.
Crossref
Crossref
Pan Gu, Tingting Fan, Stanley Sau Ching Wong, Zhiqiang Pan, Wai Lydia Tai, Sookja Kim Chung & Chi Wai Cheung. (2021) Central Endothelin-1 Confers Analgesia by Triggering Spinal Neuronal Histone Deacetylase 5 (HDAC5) Nuclear Exclusion in Peripheral Neuropathic Pain in Mice. The Journal of Pain 22:4, pages 454-471.
Crossref
Crossref
Marina Barreto Felisbino, Mark Ziemann, Ishant Khurana, Jun Okabe, Keith Al-Hasani, Scott Maxwell, K. N. Harikrishnan, Camila Borges Martins de Oliveira, Maria Luiza S. Mello & Assam El-Osta. (2021) Valproic acid influences the expression of genes implicated with hyperglycaemia-induced complement and coagulation pathways. Scientific Reports 11:1.
Crossref
Crossref
Andrea S. Pereyra, Kate L. Harris, Arvin H. Soepriatna, Quin A. Waterbury, Sivakama S. Bharathi, Yuxun Zhang, Kelsey H. Fisher-Wellman, Craig J. Goergen, Eric S. Goetzman & Jessica M. Ellis. (2021) Octanoate is differentially metabolized in liver and muscle and fails to rescue cardiomyopathy in CPT2 deficiency. Journal of Lipid Research 62, pages 100069.
Crossref
Crossref
Kornelia Jaquet, Andreas Mügge & Nazha Hamdani. 2021. Epigenetics in Cardiovascular Disease. Epigenetics in Cardiovascular Disease
187
211
.
Preethika Ekanayake, Christopher Hupfeld & Sunder Mudaliar. (2020) Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad. Current Diabetes Reports 20:12.
Crossref
Crossref
Speranza Rubattu, Rosita Stanzione, Maria Cotugno, Franca Bianchi, Simona Marchitti & Maurizio Forte. (2020) Epigenetic control of natriuretic peptides: implications for health and disease. Cellular and Molecular Life Sciences 77:24, pages 5121-5130.
Crossref
Crossref
Ulf Landmesser, Wolfgang Poller, Sotirios Tsimikas, Patrick Most, Francesco Paneni & Thomas F Lüscher. (2020) From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases. European Heart Journal 41:40, pages 3884-3899.
Crossref
Crossref
Mingjie Yang, Yingmei Zhang & Jun Ren. (2020) Acetylation in cardiovascular diseases: Molecular mechanisms and clinical implications. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866:10, pages 165836.
Crossref
Crossref
Chris R. Bain, Mark Ziemann, Antony Kaspi, Abdul Waheed Khan, Rachael Taylor, Hugh Trahair, Ishant Khurana, Harikrishnan Kaipananickal, Sophie Wallace, Assam El‐Osta, Paul S. Myles & Kiymet Bozaoglu. (2020) DNA methylation patterns from peripheral blood separate coronary artery disease patients with and without heart failure. ESC Heart Failure 7:5, pages 2468-2478.
Crossref
Crossref
He Zhang, Lu Ji, Yue Yang, Xiaoning Zhang, Yi Gang & Lunhao Bai. (2020) The Role of HDACs and HDACi in Cartilage and Osteoarthritis. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Jessica PflegerRyan C. ColemanJessica Ibetti, Rajika RoyIoannis D. Kyriazis, Erhe GaoKonstantinos Drosatos & Walter J. Koch. (2020) Genomic Binding Patterns of Forkhead Box Protein O1 Reveal Its Unique Role in Cardiac Hypertrophy. Circulation 142:9, pages 882-898.
Crossref
Crossref
Likai Shi, Zhenpu Tian, Qiang Fu, Hao Li, Lifeng Zhang, Li Tian & Weidong Mi. (2020) miR-217-regulated MEF2D-HDAC5/ND6 signaling pathway participates in the oxidative stress and inflammatory response after cerebral ischemia. Brain Research 1739, pages 146835.
Crossref
Crossref
Levi W. Evans, Maheshi Athukorala, Kristina Martinez-Guryn & Bradley S. Ferguson. (2020) The Role of Histone Acetylation and the Microbiome in Phytochemical Efficacy for Cardiovascular Diseases. International Journal of Molecular Sciences 21:11, pages 4006.
Crossref
Crossref
Levi W. Evans, Matthew S. Stratton & Bradley S. Ferguson. (2020) Dietary natural products as epigenetic modifiers in aging-associated inflammation and disease. Natural Product Reports 37:5, pages 653-676.
Crossref
Crossref
Hao Jiang, Daile Jia, Beijian Zhang, Wenlong Yang, Zhen Dong, Xiaolei Sun, Xiaotong Cui, Leilei Ma, Jian Wu, Kai Hu, Aijun Sun & Junbo Ge. (2020) Exercise improves cardiac function and glucose metabolism in mice with experimental myocardial infarction through inhibiting HDAC4 and upregulating GLUT1 expression. Basic Research in Cardiology 115:3.
Crossref
Crossref
Takatomo Watanabe, Hideshi Okada, Hiromitsu Kanamori, Nagisa Miyazaki, Akiko Tsujimoto, Chihiro Takada, Kodai Suzuki, Genki Naruse, Akihiro Yoshida, Takahide Nawa, Toshiki Tanaka, Masanori Kawasaki, Hiroyasu Ito, Shinji Ogura, Hiroyuki Okura, Takako Fujiwara, Hisayoshi Fujiwara & Genzou Takemura. (2020)
In situ
nuclear DNA methylation in dilated cardiomyopathy: an endomyocardial biopsy study
. ESC Heart Failure 7:2, pages 493-502.
Crossref
Crossref
Min Cong, Yuan Wang, Yang Yang, Cheng Lian, Xueqian Zhuang, Xiaoxun Li, Peiyuan Zhang, Yingjie Liu, Jun Tang, Qifeng Yang, Xue Zhang, Hua Xiong, Ronggui Hu & Guohong Hu. (2020) MTSS1 suppresses mammary tumor-initiating cells by enhancing RBCK1-mediated p65 ubiquitination. Nature Cancer 1:2, pages 222-234.
Crossref
Crossref
Markus Wallner, Deborah M. Eaton, Remus M. BerrettaLaura LiesingerMatthias Schittmayer, Juergen Gindlhuber, Jichuan Wu, Mark Y. JeongYing H. Lin, Giulia BorghettiSandy T. Baker, Huaqing ZhaoJessica Pfleger, Sandra BlassPeter P. Rainer, Dirk von LewinskiHeiko BuggerSadia MohsinWolfgang F. Graier, Andreas ZirlikTimothy A. McKinsey, Ruth Birner-Gruenberger, Marla R. Wolfson & Steven R. Houser. (2020) HDAC inhibition improves cardiopulmonary function in a feline model of diastolic dysfunction. Science Translational Medicine 12:525.
Crossref
Crossref
Justine S. Habibian & Bradley S. Ferguson. 2020. Histone Modifications in Therapy. Histone Modifications in Therapy
337
359
.
H. JUNG, E. LEE, I. KIM, J. SONG & G. KIM. (2019) Histone Deacetylase Inhibition has Cardiac and Vascular Protective Effects in Rats With Pressure Overload Cardiac Hypertrophy. Physiological Research, pages 727-737.
Crossref
Crossref
Congping Su, Qing Wang, Huimin Zhang, Wenchao Jiao, Hui Luo, Lin Li, Xiangyang Chen, Bin Liu, Xue Yu, Sen Li, Wei Wang & Shuzhen Guo. (2019) Si-Miao-Yong-An Decoction Protects Against Cardiac Hypertrophy and Dysfunction by Inhibiting Platelet Aggregation and Activation. Frontiers in Pharmacology 10.
Crossref
Crossref
Rebecca L McIntyre, Eileen G Daniels, Marte Molenaars, Riekelt H Houtkooper & Georges E Janssens. (2019) From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs. EMBO Molecular Medicine 11:9.
Crossref
Crossref
Francesca Forini, Giuseppina Nicolini, Letizia Pitto & Giorgio Iervasi. (2019) Novel Insight Into the Epigenetic and Post-transcriptional Control of Cardiac Gene Expression by Thyroid Hormone. Frontiers in Endocrinology 10.
Crossref
Crossref
Ryan S. Stowers, Anna Shcherbina, Johnny Israeli, Joshua J. Gruber, Julie Chang, Sungmin Nam, Atefeh Rabiee, Mary N. Teruel, Michael P. Snyder, Anshul Kundaje & Ovijit Chaudhuri. (2019) Matrix stiffness induces a tumorigenic phenotype in mammary epithelium through changes in chromatin accessibility. Nature Biomedical Engineering 3:12, pages 1009-1019.
Crossref
Crossref
Njabulo Ngwenyama, Ane M. Salvador, Francisco Velázquez, Tania Nevers, Alexander Levy, Mark Aronovitz, Andrew D. Luster, Gordon S. Huggins & Pilar Alcaide. (2019) CXCR3 regulates CD4+ T cell cardiotropism in pressure overload–induced cardiac dysfunction. JCI Insight 4:7.
Crossref
Crossref
Wenbo Li & Zheng Sun. (2019) Mechanism of Action for HDAC Inhibitors—Insights from Omics Approaches. International Journal of Molecular Sciences 20:7, pages 1616.
Crossref
Crossref
Himavanth Gatla, Nethaji Muniraj, Prashanth Thevkar, Siddhartha Yavvari, Sahithi Sukhavasi & Monish Makena. (2019) Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases. International Journal of Molecular Sciences 20:5, pages 1110.
Crossref
Crossref
Beatrix ScholzJan Sebastian SchulteSabine HamerKirsten HimmlerFlorentina PluteanuMatthias Dodo SeidlJuliane SteinEva WardelmannElke HammerUwe VölkerFrank Ulrich Müller. (2019) HDAC (Histone Deacetylase) Inhibitor Valproic Acid Attenuates Atrial Remodeling and Delays the Onset of Atrial Fibrillation in Mice. Circulation: Arrhythmia and Electrophysiology 12:3.
Crossref
Crossref
Keith Al-Hasani, Prabhu Mathiyalagan & Assam El-Osta. (2019) Epigenetics, cardiovascular disease, and cellular reprogramming. Journal of Molecular and Cellular Cardiology 128, pages 129-133.
Crossref
Crossref
Alexander E. Berezin. (2019) Prognostication of clinical outcomes in diabetes mellitus: Emerging role of cardiac biomarkers. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13:2, pages 995-1003.
Crossref
Crossref
Xing Lyu, Min Hu, Jieting Peng, Xiangyu Zhang & Yan Y Sanders. (2019) HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis. Therapeutic Advances in Chronic Disease 10, pages 204062231986269.
Crossref
Crossref
A. Ganesan. 2020. Chemical Epigenetics. Chemical Epigenetics
1
27
.
Justine Habibian & Bradley Ferguson. (2018) The Crosstalk between Acetylation and Phosphorylation: Emerging New Roles for HDAC Inhibitors in the Heart. International Journal of Molecular Sciences 20:1, pages 102.
Crossref
Crossref
Caryn Carson & Heather A. Lawson. (2018) Epigenetics of metabolic syndrome. Physiological Genomics 50:11, pages 947-955.
Crossref
Crossref
Levi Evans & Bradley Ferguson. (2018) Food Bioactive HDAC Inhibitors in the Epigenetic Regulation of Heart Failure. Nutrients 10:8, pages 1120.
Crossref
Crossref
Oscar H. L. Bing. (2018) Hypothesis: role for ammonia neutralization in the prevention and reversal of heart failure. American Journal of Physiology-Heart and Circulatory Physiology 314:5, pages H1049-H1052.
Crossref
Crossref
Adam Russell‐Hallinan, Chris J. Watson & John A. Baugh. 2011. Comprehensive Physiology. Comprehensive Physiology
451
491
.
Almin I. Lalani, Sining Zhu, Samantha Gokhale, Juan Jin & Ping Xie. (2017) TRAF Molecules in Inflammation and Inflammatory Diseases. Current Pharmacology Reports 4:1, pages 64-90.
Crossref
Crossref
Timothy A. McKinsey, Thomas M. Vondriska & Yibin Wang. (2018) Epigenomic regulation of heart failure: integrating histone marks, long noncoding RNAs, and chromatin architecture. F1000Research 7, pages 1713.
Crossref
Crossref
Christine M. Cunningham & Mansoureh Eghbali. 2018. Sex-Specific Analysis of Cardiovascular Function. Sex-Specific Analysis of Cardiovascular Function
31
47
.
Andrea S. Pereyra, Like Y. Hasek, Kate L. Harris, Alycia G. Berman, Frederick W. Damen, Craig J. Goergen & Jessica M. Ellis. (2017) Loss of cardiac carnitine palmitoyltransferase 2 results in rapamycin-resistant, acetylation-independent hypertrophy. Journal of Biological Chemistry 292:45, pages 18443-18456.
Crossref
Crossref
Natalia Cullell, Elena Muiño, Caty Carrera, Nuria Torres, Jerzy Krupinski & Israel Fernandez-Cadenas. (2017) Role of TRAF3 in neurological and cardiovascular diseases: an overview of recent studies. Biomolecular Concepts 8:3-4, pages 197-202.
Crossref
Crossref
Zheng XuQian Tong, Zhiguo Zhang, Shudong Wang, Yang Zheng, Qiuju Liu, Ling-bo Qian, Shao-yu ChenJian Sun & Lu Cai. (2017) Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1/2 pathway. Clinical Science 131:15, pages 1841-1857.
Crossref
Crossref
My‐Nhan Nguyen, Helen Kiriazis, Xiao‐Ming Gao & Xiao‐Jun Du. 2011. Comprehensive Physiology. Comprehensive Physiology
1009
1049
.
Hanah Rodriguez, Haloom Rafehi, Mrinal Bhave & Assam El-Osta. (2017) Metabolism and chromatin dynamics in health and disease. Molecular Aspects of Medicine 54, pages 1-15.
Crossref
Crossref
Tzipora C Falik‐Zaccai, Yiftah Barsheshet, Hanna Mandel, Meital Segev, Avraham Lorber, Shachaf Gelberg, Limor Kalfon, Shani Ben Haroush, Adel Shalata, Liat Gelernter‐Yaniv, Sarah Chaim, Dorith Raviv Shay, Morad Khayat, Michal Werbner, Inbar Levi, Yishay Shoval, Galit Tal, Stavit Shalev, Eli Reuveni, Emily Avitan‐Hersh, Eugene Vlodavsky, Liat Appl‐Sarid, Dorit Goldsher, Reuven Bergman, Zvi Segal, Ora Bitterman‐Deutsch & Orly Avni. (2017)
Sequence variation in
PPP
1R13L
results in a novel form of cardio‐cutaneous syndrome
. EMBO Molecular Medicine 9:3, pages 319-336.
Crossref
Crossref
Chiara Cencioni, Sandra Atlante, Matteo Savoia, Fabio Martelli, Antonella Farsetti, Maurizio C. Capogrossi, Andreas M. Zeiher, Carlo Gaetano & Francesco Spallotta. (2017) The double life of cardiac mesenchymal cells: Epimetabolic sensors and therapeutic assets for heart regeneration. Pharmacology & Therapeutics 171, pages 43-55.
Crossref
Crossref
Christian Fork, Andrea E. Vasconez, Patrick Janetzko, Carlo Angioni, Yannick Schreiber, Nerea Ferreirós, Gerd Geisslinger, Matthias S. Leisegang, Dieter Steinhilber & Ralf P. Brandes. (2017) Epigenetic control of microsomal prostaglandin E synthase-1 by HDAC-mediated recruitment of p300. Journal of Lipid Research 58:2, pages 386-392.
Crossref
Crossref
Dimitry A. Chistiakov, Alexander N. Orekhov & Yuri V. Bobryshev. (2017) Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation. International Journal of Cardiology 227, pages 66-82.
Crossref
Crossref
Susanne Voelter-Mahlknecht. (2016) Epigenetic associations in relation to cardiovascular prevention and therapeutics. Clinical Epigenetics 8:1.
Crossref
Crossref
Alexander Berezin. (2016) Epigenetics in heart failure phenotypes. BBA Clinical 6, pages 31-37.
Crossref
Crossref
Amit Mandoli, Abhishek A. Singh, Koen H.M. Prange, Esther Tijchon, Marjolein Oerlemans, Rene Dirks, Menno Ter Huurne, Albertus T.J. Wierenga, Eva M. Janssen-Megens, Kim Berentsen, Nilofar Sharifi, Bowon Kim, Filomena Matarese, Luan N. Nguyen, Nina C. Hubner, Nagesha A. Rao, Emile van den Akker, Lucia Altucci, Edo Vellenga, Hendrik G. Stunnenberg & Joost H.A. Martens. (2016) The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs. Cell Reports 17:8, pages 2087-2100.
Crossref
Crossref
Feng Chen, Xueyi Li, Emily Aquadro, Stephen Haigh, Jiliang Zhou, David W. Stepp, Neal L. Weintraub, Scott A. Barman & David J.R. Fulton. (2016) Inhibition of histone deacetylase reduces transcription of NADPH oxidases and ROS production and ameliorates pulmonary arterial hypertension. Free Radical Biology and Medicine 99, pages 167-178.
Crossref
Crossref
Xiaofan Li, Xiaoyan Guan, Fang Li, Yuanzhong Chen & Nainong Li. (2016) Chemosensitivity enhancement toward arsenic trioxide by inhibition of histone deacetylase in NB4 cell line. Journal of International Medical Research 44:4, pages 882-892.
Crossref
Crossref
Ying-Hsi Lin, Chad M. Warren, Jieli Li, Timothy A. McKinsey & Brenda Russell. (2016) Myofibril growth during cardiac hypertrophy is regulated through dual phosphorylation and acetylation of the actin capping protein CapZ. Cellular Signalling 28:8, pages 1015-1024.
Crossref
Crossref
Haloom Rafehi & Assam El-Osta. (2016) HDAC Inhibition in Vascular Endothelial Cells Regulates the Expression of ncRNAs. Non-Coding RNA 2:2, pages 4.
Crossref
Crossref
Raffaele AltaraMarco Manca, Rita D. Brandão, Asad Zeidan, George W. BoozFouad A. Zouein. (2016) Emerging importance of chemokine receptor CXCR3 and its ligands in cardiovascular diseases. Clinical Science 130:7, pages 463-478.
Crossref
Crossref
Matthew S. Stratton & Timothy A. McKinsey. (2016) Epigenetic regulation of cardiac fibrosis. Journal of Molecular and Cellular Cardiology 92, pages 206-213.
Crossref
Crossref
Eunjo LeeMin-ji SongHae-Ahm LeeSeol-Hee KangMina KimEun Kyoung YangDo Young LeeSeonggu RoJoong Myung ChoInkyeom Kim. (2016) Histone deacetylase inhibitor, CG200745, attenuates cardiac hypertrophy and fibrosis in DOCA-induced hypertensive rats. The Korean Journal of Physiology & Pharmacology 20:5, pages 477.
Crossref
Crossref
V. Moresi, N. Marroncelli, E. Pigna & S. Adamo. 2016. Medical Epigenetics. Medical Epigenetics
315
333
.
Weston W. Blakeslee, Philip D. Tatman & Timothy A. McKinsey. 2016. Epigenetics in Cardiac Disease. Epigenetics in Cardiac Disease
209
229
.